nodes	percent_of_prediction	percent_of_DWPC	metapath
Adenosine—SLC28A3—prostate gland—prostate cancer	0.0158	0.0908	CbGeAlD
Adenosine—ADORA2B—prostate gland—prostate cancer	0.0113	0.0647	CbGeAlD
Adenosine—ADA—prostate gland—prostate cancer	0.0103	0.0592	CbGeAlD
Adenosine—ADK—prostate gland—prostate cancer	0.00842	0.0484	CbGeAlD
Adenosine—DPP4—prostate gland—prostate cancer	0.00817	0.0469	CbGeAlD
Adenosine—SLC28A3—bone marrow—prostate cancer	0.00815	0.0468	CbGeAlD
Adenosine—ADORA2B—urethra—prostate cancer	0.00755	0.0433	CbGeAlD
Adenosine—ADK—seminal vesicle—prostate cancer	0.00712	0.0409	CbGeAlD
Adenosine—ADA—renal system—prostate cancer	0.00703	0.0403	CbGeAlD
Adenosine—DPP4—seminal vesicle—prostate cancer	0.00691	0.0397	CbGeAlD
Adenosine—DPP4—epithelium—prostate cancer	0.006	0.0345	CbGeAlD
Adenosine—ADK—renal system—prostate cancer	0.00574	0.033	CbGeAlD
Adenosine—ADK—urethra—prostate cancer	0.00564	0.0324	CbGeAlD
Adenosine—DPP4—renal system—prostate cancer	0.00557	0.032	CbGeAlD
Adenosine—ADORA1—renal system—prostate cancer	0.00552	0.0317	CbGeAlD
Adenosine—ADORA1—urethra—prostate cancer	0.00542	0.0311	CbGeAlD
Adenosine—ADA—bone marrow—prostate cancer	0.00531	0.0305	CbGeAlD
Adenosine—ADORA2B—testis—prostate cancer	0.00497	0.0285	CbGeAlD
Adenosine—ADA—testis—prostate cancer	0.00454	0.0261	CbGeAlD
Adenosine—ADK—bone marrow—prostate cancer	0.00434	0.0249	CbGeAlD
Adenosine—DPP4—bone marrow—prostate cancer	0.00421	0.0242	CbGeAlD
Adenosine—ADORA2A—testis—prostate cancer	0.00413	0.0237	CbGeAlD
Adenosine—ADK—testis—prostate cancer	0.00371	0.0213	CbGeAlD
Adenosine—DPP4—testis—prostate cancer	0.0036	0.0207	CbGeAlD
Adenosine—ADORA1—testis—prostate cancer	0.00357	0.0205	CbGeAlD
Adenosine—S-Adenosylmethionine—GNMT—prostate cancer	0.00348	0.201	CrCbGaD
Adenosine—ADA—lymph node—prostate cancer	0.00329	0.0189	CbGeAlD
Adenosine—ADK—lymph node—prostate cancer	0.00269	0.0154	CbGeAlD
Adenosine—DPP4—lymph node—prostate cancer	0.00261	0.015	CbGeAlD
Adenosine—ADORA1—lymph node—prostate cancer	0.00259	0.0148	CbGeAlD
Adenosine—Azacitidine—DNMT1—prostate cancer	0.00221	0.128	CrCbGaD
Adenosine—Decitabine—DNMT1—prostate cancer	0.00216	0.125	CrCbGaD
Adenosine—Adenosine triphosphate—HSPA1A—prostate cancer	0.00197	0.114	CrCbGaD
Adenosine—Glucosamine—MMP9—prostate cancer	0.0012	0.0694	CrCbGaD
Adenosine—S-Adenosylmethionine—COMT—prostate cancer	0.000893	0.0517	CrCbGaD
Adenosine—Adenosine monophosphate—PDE4D—prostate cancer	0.00087	0.0503	CrCbGaD
Adenosine—Adenosine triphosphate—AKT1—prostate cancer	0.000771	0.0446	CrCbGaD
Adenosine—Adenosine monophosphate—SRC—prostate cancer	0.00076	0.044	CrCbGaD
Adenosine—Glucosamine—CYP2E1—prostate cancer	0.000607	0.0351	CrCbGaD
Adenosine—Glucosamine—CYP2C19—prostate cancer	0.000601	0.0348	CrCbGaD
Adenosine—Cytarabine—SLC22A1—prostate cancer	0.000592	0.0342	CrCbGaD
Adenosine—Cladribine—SLC22A1—prostate cancer	0.000545	0.0315	CrCbGaD
Adenosine—S-Adenosylmethionine—CYP2E1—prostate cancer	0.000416	0.0241	CrCbGaD
Adenosine—Acute coronary syndrome—Prednisone—prostate cancer	0.00037	0.000716	CcSEcCtD
Adenosine—Pain—Estradiol—prostate cancer	0.000369	0.000713	CcSEcCtD
Adenosine—Myocardial infarction—Prednisone—prostate cancer	0.000368	0.000712	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Mitoxantrone—prostate cancer	0.000366	0.000708	CcSEcCtD
Adenosine—Flushing—Docetaxel—prostate cancer	0.000363	0.000702	CcSEcCtD
Adenosine—Cardiac disorder—Docetaxel—prostate cancer	0.000363	0.000702	CcSEcCtD
Adenosine—Cardiac arrest—Epirubicin—prostate cancer	0.000362	0.000701	CcSEcCtD
Adenosine—Cardiac failure—Doxorubicin—prostate cancer	0.000361	0.000699	CcSEcCtD
Adenosine—Mood swings—Epirubicin—prostate cancer	0.000361	0.000699	CcSEcCtD
Adenosine—Paraesthesia—Mitoxantrone—prostate cancer	0.000361	0.000698	CcSEcCtD
Adenosine—Loss of consciousness—Etoposide—prostate cancer	0.00036	0.000696	CcSEcCtD
Adenosine—Cerebrovascular accident—Doxorubicin—prostate cancer	0.00036	0.000696	CcSEcCtD
Adenosine—Dizziness—Goserelin—prostate cancer	0.00036	0.000696	CcSEcCtD
Adenosine—Dyspnoea—Mitoxantrone—prostate cancer	0.000358	0.000693	CcSEcCtD
Adenosine—Cough—Etoposide—prostate cancer	0.000357	0.000691	CcSEcCtD
Adenosine—Somnolence—Mitoxantrone—prostate cancer	0.000357	0.000691	CcSEcCtD
Adenosine—Dizziness—Conjugated Estrogens—prostate cancer	0.000356	0.000689	CcSEcCtD
Adenosine—Convulsion—Etoposide—prostate cancer	0.000355	0.000686	CcSEcCtD
Adenosine—Hypertension—Etoposide—prostate cancer	0.000353	0.000684	CcSEcCtD
Adenosine—Tinnitus—Capecitabine—prostate cancer	0.000353	0.000683	CcSEcCtD
Adenosine—Mediastinal disorder—Docetaxel—prostate cancer	0.000352	0.000682	CcSEcCtD
Adenosine—Flushing—Capecitabine—prostate cancer	0.000351	0.00068	CcSEcCtD
Adenosine—Cardiac disorder—Capecitabine—prostate cancer	0.000351	0.00068	CcSEcCtD
Adenosine—Arrhythmia—Docetaxel—prostate cancer	0.000349	0.000676	CcSEcCtD
Adenosine—Chest pain—Etoposide—prostate cancer	0.000348	0.000675	CcSEcCtD
Adenosine—Affect lability—Doxorubicin—prostate cancer	0.000347	0.000672	CcSEcCtD
Adenosine—Vomiting—Goserelin—prostate cancer	0.000346	0.000669	CcSEcCtD
Adenosine—Discomfort—Etoposide—prostate cancer	0.000344	0.000666	CcSEcCtD
Adenosine—Pain—Mitoxantrone—prostate cancer	0.000343	0.000665	CcSEcCtD
Adenosine—Bradycardia—Prednisone—prostate cancer	0.000343	0.000664	CcSEcCtD
Adenosine—Rash—Goserelin—prostate cancer	0.000343	0.000664	CcSEcCtD
Adenosine—Dermatitis—Goserelin—prostate cancer	0.000343	0.000663	CcSEcCtD
Adenosine—Vomiting—Conjugated Estrogens—prostate cancer	0.000342	0.000663	CcSEcCtD
Adenosine—Urticaria—Estradiol—prostate cancer	0.000342	0.000663	CcSEcCtD
Adenosine—Mediastinal disorder—Capecitabine—prostate cancer	0.000341	0.00066	CcSEcCtD
Adenosine—Headache—Goserelin—prostate cancer	0.000341	0.000659	CcSEcCtD
Adenosine—Rash—Conjugated Estrogens—prostate cancer	0.00034	0.000657	CcSEcCtD
Adenosine—Dermatitis—Conjugated Estrogens—prostate cancer	0.000339	0.000657	CcSEcCtD
Adenosine—Arrhythmia—Capecitabine—prostate cancer	0.000338	0.000654	CcSEcCtD
Adenosine—Headache—Conjugated Estrogens—prostate cancer	0.000337	0.000653	CcSEcCtD
Adenosine—Cardiac arrest—Doxorubicin—prostate cancer	0.000335	0.000649	CcSEcCtD
Adenosine—Anaphylactic shock—Etoposide—prostate cancer	0.000334	0.000647	CcSEcCtD
Adenosine—Mood swings—Doxorubicin—prostate cancer	0.000334	0.000646	CcSEcCtD
Adenosine—Dysgeusia—Docetaxel—prostate cancer	0.000333	0.000645	CcSEcCtD
Adenosine—Back pain—Docetaxel—prostate cancer	0.000329	0.000637	CcSEcCtD
Adenosine—Tachycardia—Etoposide—prostate cancer	0.000326	0.000631	CcSEcCtD
Adenosine—Nausea—Goserelin—prostate cancer	0.000323	0.000625	CcSEcCtD
Adenosine—Hyperhidrosis—Etoposide—prostate cancer	0.000323	0.000625	CcSEcCtD
Adenosine—Dysgeusia—Capecitabine—prostate cancer	0.000323	0.000624	CcSEcCtD
Adenosine—Nausea—Conjugated Estrogens—prostate cancer	0.00032	0.000619	CcSEcCtD
Adenosine—Urticaria—Mitoxantrone—prostate cancer	0.000319	0.000618	CcSEcCtD
Adenosine—Back pain—Capecitabine—prostate cancer	0.000319	0.000617	CcSEcCtD
Adenosine—Hypersensitivity—Estradiol—prostate cancer	0.000318	0.000615	CcSEcCtD
Adenosine—Flushing—Prednisone—prostate cancer	0.000313	0.000605	CcSEcCtD
Adenosine—Hypotension—Etoposide—prostate cancer	0.000312	0.000604	CcSEcCtD
Adenosine—Vision blurred—Capecitabine—prostate cancer	0.00031	0.000601	CcSEcCtD
Adenosine—Asthenia—Estradiol—prostate cancer	0.000309	0.000599	CcSEcCtD
Adenosine—Tremor—Capecitabine—prostate cancer	0.000309	0.000597	CcSEcCtD
Adenosine—Syncope—Docetaxel—prostate cancer	0.000305	0.00059	CcSEcCtD
Adenosine—Pollakiuria—Epirubicin—prostate cancer	0.000304	0.000589	CcSEcCtD
Adenosine—Arrhythmia—Prednisone—prostate cancer	0.000301	0.000583	CcSEcCtD
Adenosine—Palpitations—Docetaxel—prostate cancer	0.000301	0.000582	CcSEcCtD
Adenosine—Paraesthesia—Etoposide—prostate cancer	0.0003	0.000581	CcSEcCtD
Adenosine—Loss of consciousness—Docetaxel—prostate cancer	0.000299	0.000579	CcSEcCtD
Adenosine—Dyspnoea—Etoposide—prostate cancer	0.000298	0.000577	CcSEcCtD
Adenosine—Somnolence—Etoposide—prostate cancer	0.000297	0.000575	CcSEcCtD
Adenosine—Cough—Docetaxel—prostate cancer	0.000297	0.000575	CcSEcCtD
Adenosine—Hypersensitivity—Mitoxantrone—prostate cancer	0.000296	0.000573	CcSEcCtD
Adenosine—Syncope—Capecitabine—prostate cancer	0.000295	0.000572	CcSEcCtD
Adenosine—Convulsion—Docetaxel—prostate cancer	0.000295	0.000571	CcSEcCtD
Adenosine—Hypertension—Docetaxel—prostate cancer	0.000294	0.000568	CcSEcCtD
Adenosine—Drowsiness—Epirubicin—prostate cancer	0.000294	0.000568	CcSEcCtD
Adenosine—Palpitations—Capecitabine—prostate cancer	0.000291	0.000563	CcSEcCtD
Adenosine—Chest pain—Docetaxel—prostate cancer	0.00029	0.000561	CcSEcCtD
Adenosine—Loss of consciousness—Capecitabine—prostate cancer	0.000289	0.00056	CcSEcCtD
Adenosine—Asthenia—Mitoxantrone—prostate cancer	0.000288	0.000558	CcSEcCtD
Adenosine—Cough—Capecitabine—prostate cancer	0.000287	0.000556	CcSEcCtD
Adenosine—Pain—Etoposide—prostate cancer	0.000286	0.000553	CcSEcCtD
Adenosine—Dizziness—Estradiol—prostate cancer	0.000285	0.000552	CcSEcCtD
Adenosine—Hypertension—Capecitabine—prostate cancer	0.000284	0.00055	CcSEcCtD
Adenosine—Dry mouth—Docetaxel—prostate cancer	0.000283	0.000548	CcSEcCtD
Adenosine—Sweating—Epirubicin—prostate cancer	0.000281	0.000545	CcSEcCtD
Adenosine—Pollakiuria—Doxorubicin—prostate cancer	0.000281	0.000545	CcSEcCtD
Adenosine—Chest pain—Capecitabine—prostate cancer	0.00028	0.000543	CcSEcCtD
Adenosine—Anxiety—Capecitabine—prostate cancer	0.000279	0.000541	CcSEcCtD
Adenosine—Anaphylactic shock—Docetaxel—prostate cancer	0.000278	0.000537	CcSEcCtD
Adenosine—Discomfort—Capecitabine—prostate cancer	0.000277	0.000536	CcSEcCtD
Adenosine—Vision blurred—Prednisone—prostate cancer	0.000276	0.000535	CcSEcCtD
Adenosine—Dry mouth—Capecitabine—prostate cancer	0.000274	0.000531	CcSEcCtD
Adenosine—Vomiting—Estradiol—prostate cancer	0.000274	0.00053	CcSEcCtD
Adenosine—Shock—Docetaxel—prostate cancer	0.000273	0.000529	CcSEcCtD
Adenosine—Rash—Estradiol—prostate cancer	0.000272	0.000526	CcSEcCtD
Adenosine—Drowsiness—Doxorubicin—prostate cancer	0.000272	0.000526	CcSEcCtD
Adenosine—Dermatitis—Estradiol—prostate cancer	0.000272	0.000526	CcSEcCtD
Adenosine—Tachycardia—Docetaxel—prostate cancer	0.000271	0.000524	CcSEcCtD
Adenosine—Headache—Estradiol—prostate cancer	0.00027	0.000523	CcSEcCtD
Adenosine—Agitation—Prednisone—prostate cancer	0.00027	0.000522	CcSEcCtD
Adenosine—Bradycardia—Epirubicin—prostate cancer	0.000268	0.000519	CcSEcCtD
Adenosine—Angioedema—Prednisone—prostate cancer	0.000268	0.000519	CcSEcCtD
Adenosine—Urticaria—Etoposide—prostate cancer	0.000265	0.000514	CcSEcCtD
Adenosine—Shock—Capecitabine—prostate cancer	0.000264	0.000512	CcSEcCtD
Adenosine—Syncope—Prednisone—prostate cancer	0.000263	0.000509	CcSEcCtD
Adenosine—Tachycardia—Capecitabine—prostate cancer	0.000262	0.000508	CcSEcCtD
Adenosine—Hypoaesthesia—Epirubicin—prostate cancer	0.000262	0.000508	CcSEcCtD
Adenosine—Sweating—Doxorubicin—prostate cancer	0.00026	0.000504	CcSEcCtD
Adenosine—Hyperhidrosis—Capecitabine—prostate cancer	0.00026	0.000503	CcSEcCtD
Adenosine—Hypotension—Docetaxel—prostate cancer	0.000259	0.000502	CcSEcCtD
Adenosine—Loss of consciousness—Prednisone—prostate cancer	0.000258	0.000499	CcSEcCtD
Adenosine—Nausea—Estradiol—prostate cancer	0.000256	0.000496	CcSEcCtD
Adenosine—Vomiting—Mitoxantrone—prostate cancer	0.000255	0.000494	CcSEcCtD
Adenosine—Convulsion—Prednisone—prostate cancer	0.000254	0.000492	CcSEcCtD
Adenosine—Hypertension—Prednisone—prostate cancer	0.000253	0.00049	CcSEcCtD
Adenosine—Rash—Mitoxantrone—prostate cancer	0.000253	0.00049	CcSEcCtD
Adenosine—Dermatitis—Mitoxantrone—prostate cancer	0.000253	0.00049	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Docetaxel—prostate cancer	0.000253	0.00049	CcSEcCtD
Adenosine—Headache—Mitoxantrone—prostate cancer	0.000252	0.000487	CcSEcCtD
Adenosine—Hypotension—Capecitabine—prostate cancer	0.000251	0.000486	CcSEcCtD
Adenosine—Paraesthesia—Docetaxel—prostate cancer	0.000249	0.000483	CcSEcCtD
Adenosine—Anxiety—Prednisone—prostate cancer	0.000249	0.000482	CcSEcCtD
Adenosine—Bradycardia—Doxorubicin—prostate cancer	0.000248	0.000481	CcSEcCtD
Adenosine—Dyspnoea—Docetaxel—prostate cancer	0.000248	0.000479	CcSEcCtD
Adenosine—Somnolence—Docetaxel—prostate cancer	0.000247	0.000478	CcSEcCtD
Adenosine—Discomfort—Prednisone—prostate cancer	0.000247	0.000478	CcSEcCtD
Adenosine—Hypersensitivity—Etoposide—prostate cancer	0.000246	0.000476	CcSEcCtD
Adenosine—Tinnitus—Epirubicin—prostate cancer	0.000246	0.000476	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Capecitabine—prostate cancer	0.000245	0.000474	CcSEcCtD
Adenosine—Flushing—Epirubicin—prostate cancer	0.000245	0.000474	CcSEcCtD
Adenosine—Cardiac disorder—Epirubicin—prostate cancer	0.000245	0.000474	CcSEcCtD
Adenosine—Hypoaesthesia—Doxorubicin—prostate cancer	0.000243	0.00047	CcSEcCtD
Adenosine—Paraesthesia—Capecitabine—prostate cancer	0.000241	0.000467	CcSEcCtD
Adenosine—Asthenia—Etoposide—prostate cancer	0.00024	0.000464	CcSEcCtD
Adenosine—Dyspnoea—Capecitabine—prostate cancer	0.00024	0.000464	CcSEcCtD
Adenosine—Anaphylactic shock—Prednisone—prostate cancer	0.000239	0.000463	CcSEcCtD
Adenosine—Nausea—Mitoxantrone—prostate cancer	0.000239	0.000462	CcSEcCtD
Adenosine—Mediastinal disorder—Epirubicin—prostate cancer	0.000238	0.00046	CcSEcCtD
Adenosine—Pain—Docetaxel—prostate cancer	0.000237	0.00046	CcSEcCtD
Adenosine—Shock—Prednisone—prostate cancer	0.000236	0.000456	CcSEcCtD
Adenosine—Arrhythmia—Epirubicin—prostate cancer	0.000235	0.000456	CcSEcCtD
Adenosine—Tachycardia—Prednisone—prostate cancer	0.000234	0.000452	CcSEcCtD
Adenosine—Hyperhidrosis—Prednisone—prostate cancer	0.000231	0.000448	CcSEcCtD
Adenosine—Pain—Capecitabine—prostate cancer	0.00023	0.000445	CcSEcCtD
Adenosine—Tinnitus—Doxorubicin—prostate cancer	0.000227	0.00044	CcSEcCtD
Adenosine—Flushing—Doxorubicin—prostate cancer	0.000226	0.000438	CcSEcCtD
Adenosine—Cardiac disorder—Doxorubicin—prostate cancer	0.000226	0.000438	CcSEcCtD
Adenosine—Tension—Epirubicin—prostate cancer	0.000225	0.000436	CcSEcCtD
Adenosine—Dysgeusia—Epirubicin—prostate cancer	0.000225	0.000435	CcSEcCtD
Adenosine—Nervousness—Epirubicin—prostate cancer	0.000223	0.000431	CcSEcCtD
Adenosine—Back pain—Epirubicin—prostate cancer	0.000222	0.00043	CcSEcCtD
Adenosine—Dizziness—Etoposide—prostate cancer	0.000221	0.000428	CcSEcCtD
Adenosine—Mediastinal disorder—Doxorubicin—prostate cancer	0.00022	0.000425	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Prednisone—prostate cancer	0.000218	0.000422	CcSEcCtD
Adenosine—Arrhythmia—Doxorubicin—prostate cancer	0.000218	0.000422	CcSEcCtD
Adenosine—Vision blurred—Epirubicin—prostate cancer	0.000216	0.000419	CcSEcCtD
Adenosine—Paraesthesia—Prednisone—prostate cancer	0.000215	0.000416	CcSEcCtD
Adenosine—Urticaria—Capecitabine—prostate cancer	0.000214	0.000413	CcSEcCtD
Adenosine—Vomiting—Etoposide—prostate cancer	0.000212	0.000411	CcSEcCtD
Adenosine—Agitation—Epirubicin—prostate cancer	0.000211	0.000408	CcSEcCtD
Adenosine—Rash—Etoposide—prostate cancer	0.000211	0.000408	CcSEcCtD
Adenosine—Dermatitis—Etoposide—prostate cancer	0.00021	0.000407	CcSEcCtD
Adenosine—Headache—Etoposide—prostate cancer	0.000209	0.000405	CcSEcCtD
Adenosine—Tension—Doxorubicin—prostate cancer	0.000208	0.000403	CcSEcCtD
Adenosine—Dysgeusia—Doxorubicin—prostate cancer	0.000208	0.000402	CcSEcCtD
Adenosine—Cytarabine—CYP3A4—prostate cancer	0.000207	0.012	CrCbGaD
Adenosine—Nervousness—Doxorubicin—prostate cancer	0.000206	0.000399	CcSEcCtD
Adenosine—Syncope—Epirubicin—prostate cancer	0.000206	0.000398	CcSEcCtD
Adenosine—Back pain—Doxorubicin—prostate cancer	0.000205	0.000398	CcSEcCtD
Adenosine—Hypersensitivity—Docetaxel—prostate cancer	0.000205	0.000396	CcSEcCtD
Adenosine—Palpitations—Epirubicin—prostate cancer	0.000203	0.000392	CcSEcCtD
Adenosine—Loss of consciousness—Epirubicin—prostate cancer	0.000202	0.00039	CcSEcCtD
Adenosine—Cough—Epirubicin—prostate cancer	0.0002	0.000388	CcSEcCtD
Adenosine—Vision blurred—Doxorubicin—prostate cancer	0.0002	0.000387	CcSEcCtD
Adenosine—Asthenia—Docetaxel—prostate cancer	0.000199	0.000386	CcSEcCtD
Adenosine—Convulsion—Epirubicin—prostate cancer	0.000199	0.000385	CcSEcCtD
Adenosine—Nausea—Etoposide—prostate cancer	0.000198	0.000384	CcSEcCtD
Adenosine—Hypertension—Epirubicin—prostate cancer	0.000198	0.000383	CcSEcCtD
Adenosine—Hypersensitivity—Capecitabine—prostate cancer	0.000198	0.000383	CcSEcCtD
Adenosine—Chest pain—Epirubicin—prostate cancer	0.000195	0.000378	CcSEcCtD
Adenosine—Agitation—Doxorubicin—prostate cancer	0.000195	0.000378	CcSEcCtD
Adenosine—Anxiety—Epirubicin—prostate cancer	0.000195	0.000377	CcSEcCtD
Adenosine—Discomfort—Epirubicin—prostate cancer	0.000193	0.000374	CcSEcCtD
Adenosine—Asthenia—Capecitabine—prostate cancer	0.000193	0.000373	CcSEcCtD
Adenosine—Dry mouth—Epirubicin—prostate cancer	0.000191	0.00037	CcSEcCtD
Adenosine—Syncope—Doxorubicin—prostate cancer	0.00019	0.000369	CcSEcCtD
Adenosine—Urticaria—Prednisone—prostate cancer	0.00019	0.000368	CcSEcCtD
Adenosine—Palpitations—Doxorubicin—prostate cancer	0.000188	0.000363	CcSEcCtD
Adenosine—Anaphylactic shock—Epirubicin—prostate cancer	0.000187	0.000362	CcSEcCtD
Adenosine—Loss of consciousness—Doxorubicin—prostate cancer	0.000187	0.000361	CcSEcCtD
Adenosine—Cough—Doxorubicin—prostate cancer	0.000185	0.000359	CcSEcCtD
Adenosine—Shock—Epirubicin—prostate cancer	0.000184	0.000357	CcSEcCtD
Adenosine—Convulsion—Doxorubicin—prostate cancer	0.000184	0.000356	CcSEcCtD
Adenosine—Dizziness—Docetaxel—prostate cancer	0.000184	0.000355	CcSEcCtD
Adenosine—Hypertension—Doxorubicin—prostate cancer	0.000183	0.000355	CcSEcCtD
Adenosine—Tachycardia—Epirubicin—prostate cancer	0.000183	0.000354	CcSEcCtD
Adenosine—Hyperhidrosis—Epirubicin—prostate cancer	0.000181	0.00035	CcSEcCtD
Adenosine—Chest pain—Doxorubicin—prostate cancer	0.000181	0.00035	CcSEcCtD
Adenosine—Anxiety—Doxorubicin—prostate cancer	0.00018	0.000349	CcSEcCtD
Adenosine—Discomfort—Doxorubicin—prostate cancer	0.000179	0.000346	CcSEcCtD
Adenosine—Dizziness—Capecitabine—prostate cancer	0.000178	0.000344	CcSEcCtD
Adenosine—Dry mouth—Doxorubicin—prostate cancer	0.000177	0.000342	CcSEcCtD
Adenosine—Vomiting—Docetaxel—prostate cancer	0.000177	0.000342	CcSEcCtD
Adenosine—Hypersensitivity—Prednisone—prostate cancer	0.000176	0.000341	CcSEcCtD
Adenosine—Rash—Docetaxel—prostate cancer	0.000175	0.000339	CcSEcCtD
Adenosine—Hypotension—Epirubicin—prostate cancer	0.000175	0.000339	CcSEcCtD
Adenosine—Dermatitis—Docetaxel—prostate cancer	0.000175	0.000339	CcSEcCtD
Adenosine—Headache—Docetaxel—prostate cancer	0.000174	0.000337	CcSEcCtD
Adenosine—Anaphylactic shock—Doxorubicin—prostate cancer	0.000173	0.000335	CcSEcCtD
Adenosine—Asthenia—Prednisone—prostate cancer	0.000172	0.000333	CcSEcCtD
Adenosine—Vomiting—Capecitabine—prostate cancer	0.000171	0.000331	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Epirubicin—prostate cancer	0.000171	0.00033	CcSEcCtD
Adenosine—Shock—Doxorubicin—prostate cancer	0.00017	0.00033	CcSEcCtD
Adenosine—Rash—Capecitabine—prostate cancer	0.000169	0.000328	CcSEcCtD
Adenosine—Dermatitis—Capecitabine—prostate cancer	0.000169	0.000328	CcSEcCtD
Adenosine—Tachycardia—Doxorubicin—prostate cancer	0.000169	0.000327	CcSEcCtD
Adenosine—Headache—Capecitabine—prostate cancer	0.000168	0.000326	CcSEcCtD
Adenosine—Paraesthesia—Epirubicin—prostate cancer	0.000168	0.000325	CcSEcCtD
Adenosine—Hyperhidrosis—Doxorubicin—prostate cancer	0.000168	0.000324	CcSEcCtD
Adenosine—Dyspnoea—Epirubicin—prostate cancer	0.000167	0.000323	CcSEcCtD
Adenosine—Somnolence—Epirubicin—prostate cancer	0.000166	0.000322	CcSEcCtD
Adenosine—Nausea—Docetaxel—prostate cancer	0.000165	0.000319	CcSEcCtD
Adenosine—Hypotension—Doxorubicin—prostate cancer	0.000162	0.000313	CcSEcCtD
Adenosine—Pain—Epirubicin—prostate cancer	0.00016	0.00031	CcSEcCtD
Adenosine—Nausea—Capecitabine—prostate cancer	0.00016	0.000309	CcSEcCtD
Adenosine—Dizziness—Prednisone—prostate cancer	0.000158	0.000306	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Doxorubicin—prostate cancer	0.000158	0.000306	CcSEcCtD
Adenosine—Paraesthesia—Doxorubicin—prostate cancer	0.000156	0.000301	CcSEcCtD
Adenosine—Dyspnoea—Doxorubicin—prostate cancer	0.000154	0.000299	CcSEcCtD
Adenosine—Somnolence—Doxorubicin—prostate cancer	0.000154	0.000298	CcSEcCtD
Adenosine—Vomiting—Prednisone—prostate cancer	0.000152	0.000295	CcSEcCtD
Adenosine—Rash—Prednisone—prostate cancer	0.000151	0.000292	CcSEcCtD
Adenosine—Dermatitis—Prednisone—prostate cancer	0.000151	0.000292	CcSEcCtD
Adenosine—Headache—Prednisone—prostate cancer	0.00015	0.00029	CcSEcCtD
Adenosine—Urticaria—Epirubicin—prostate cancer	0.000149	0.000288	CcSEcCtD
Adenosine—Pain—Doxorubicin—prostate cancer	0.000148	0.000287	CcSEcCtD
Adenosine—Nausea—Prednisone—prostate cancer	0.000142	0.000275	CcSEcCtD
Adenosine—Hypersensitivity—Epirubicin—prostate cancer	0.000138	0.000267	CcSEcCtD
Adenosine—Urticaria—Doxorubicin—prostate cancer	0.000138	0.000266	CcSEcCtD
Adenosine—Asthenia—Epirubicin—prostate cancer	0.000134	0.00026	CcSEcCtD
Adenosine—Hypersensitivity—Doxorubicin—prostate cancer	0.000128	0.000247	CcSEcCtD
Adenosine—Asthenia—Doxorubicin—prostate cancer	0.000124	0.000241	CcSEcCtD
Adenosine—Dizziness—Epirubicin—prostate cancer	0.000124	0.00024	CcSEcCtD
Adenosine—Vomiting—Epirubicin—prostate cancer	0.000119	0.00023	CcSEcCtD
Adenosine—Rash—Epirubicin—prostate cancer	0.000118	0.000229	CcSEcCtD
Adenosine—Dermatitis—Epirubicin—prostate cancer	0.000118	0.000228	CcSEcCtD
Adenosine—Headache—Epirubicin—prostate cancer	0.000117	0.000227	CcSEcCtD
Adenosine—Dizziness—Doxorubicin—prostate cancer	0.000115	0.000222	CcSEcCtD
Adenosine—Nausea—Epirubicin—prostate cancer	0.000111	0.000215	CcSEcCtD
Adenosine—Vomiting—Doxorubicin—prostate cancer	0.00011	0.000213	CcSEcCtD
Adenosine—Rash—Doxorubicin—prostate cancer	0.000109	0.000211	CcSEcCtD
Adenosine—Dermatitis—Doxorubicin—prostate cancer	0.000109	0.000211	CcSEcCtD
Adenosine—Headache—Doxorubicin—prostate cancer	0.000109	0.00021	CcSEcCtD
Adenosine—Nausea—Doxorubicin—prostate cancer	0.000103	0.000199	CcSEcCtD
Adenosine—ADORA1—GPCR downstream signaling—PIK3CD—prostate cancer	5.11e-05	0.000175	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—NGFR—prostate cancer	5.06e-05	0.000173	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PRKCQ—prostate cancer	5.06e-05	0.000173	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—IGF1R—prostate cancer	5.06e-05	0.000173	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—CXCL8—prostate cancer	5.03e-05	0.000172	CbGpPWpGaD
Adenosine—ADA—Metabolism—PIK3CG—prostate cancer	5.01e-05	0.000172	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—JAK2—prostate cancer	5.01e-05	0.000172	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—MAP3K7—prostate cancer	5e-05	0.000171	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PTHLH—prostate cancer	4.97e-05	0.00017	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—TGFBR1—prostate cancer	4.97e-05	0.00017	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—AKR1C3—prostate cancer	4.89e-05	0.000168	CbGpPWpGaD
Adenosine—ADK—Metabolism—PTEN—prostate cancer	4.88e-05	0.000167	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PRKACB—prostate cancer	4.87e-05	0.000167	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—LPL—prostate cancer	4.85e-05	0.000166	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—IL2—prostate cancer	4.81e-05	0.000165	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—PDGFRB—prostate cancer	4.8e-05	0.000165	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—FGF10—prostate cancer	4.8e-05	0.000165	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—PIK3CB—prostate cancer	4.76e-05	0.000163	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—ADRB2—prostate cancer	4.75e-05	0.000163	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—THBS1—prostate cancer	4.74e-05	0.000163	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PPP3CA—prostate cancer	4.74e-05	0.000163	CbGpPWpGaD
Adenosine—ADA—Metabolism—INS—prostate cancer	4.74e-05	0.000163	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—JAK2—prostate cancer	4.69e-05	0.000161	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—ITGB3—prostate cancer	4.68e-05	0.00016	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—ANXA1—prostate cancer	4.68e-05	0.00016	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—MAP2K1—prostate cancer	4.67e-05	0.00016	CbGpPWpGaD
Adenosine—ADK—Metabolism—EP300—prostate cancer	4.66e-05	0.000159	CbGpPWpGaD
Adenosine—ADA—Metabolism—CREBBP—prostate cancer	4.65e-05	0.000159	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—PIK3CD—prostate cancer	4.64e-05	0.000159	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—IL6—prostate cancer	4.64e-05	0.000159	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—VAV3—prostate cancer	4.63e-05	0.000159	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PRKCZ—prostate cancer	4.59e-05	0.000157	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—CXCL8—prostate cancer	4.57e-05	0.000157	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—TGFBR2—prostate cancer	4.57e-05	0.000157	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—ERBB3—prostate cancer	4.54e-05	0.000156	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—FGFR2—prostate cancer	4.53e-05	0.000155	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—ITPR1—prostate cancer	4.5e-05	0.000154	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—PIK3CG—prostate cancer	4.49e-05	0.000154	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—PIK3CB—prostate cancer	4.45e-05	0.000153	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PARP1—prostate cancer	4.43e-05	0.000152	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—FGFR4—prostate cancer	4.43e-05	0.000152	CbGpPWpGaD
Adenosine—ADA—Metabolism—PIK3CD—prostate cancer	4.41e-05	0.000151	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CALCA—prostate cancer	4.38e-05	0.00015	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—IL2—prostate cancer	4.37e-05	0.00015	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—TERT—prostate cancer	4.35e-05	0.000149	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—IGF1R—prostate cancer	4.3e-05	0.000147	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—CXCL8—prostate cancer	4.28e-05	0.000147	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CXCL12—prostate cancer	4.28e-05	0.000147	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—AKT1—prostate cancer	4.28e-05	0.000146	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—JAK2—prostate cancer	4.26e-05	0.000146	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—HIF1A—prostate cancer	4.16e-05	0.000143	CbGpPWpGaD
Adenosine—ADA—Metabolism—NOS3—prostate cancer	4.16e-05	0.000143	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—LPL—prostate cancer	4.12e-05	0.000141	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—IL2—prostate cancer	4.09e-05	0.00014	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PDGFRB—prostate cancer	4.08e-05	0.00014	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—PIK3CG—prostate cancer	4.07e-05	0.00014	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—LEP—prostate cancer	4.06e-05	0.000139	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—PIK3CB—prostate cancer	4.04e-05	0.000139	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CASP9—prostate cancer	4.03e-05	0.000138	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CAV1—prostate cancer	4.02e-05	0.000138	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—KDR—prostate cancer	3.98e-05	0.000136	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—ITGB3—prostate cancer	3.98e-05	0.000136	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—PIK3CD—prostate cancer	3.94e-05	0.000135	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—NGFR—prostate cancer	3.9e-05	0.000134	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PRKCQ—prostate cancer	3.9e-05	0.000134	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—CXCL8—prostate cancer	3.89e-05	0.000133	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—ESR1—prostate cancer	3.88e-05	0.000133	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—ERBB3—prostate cancer	3.86e-05	0.000132	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—MAP3K7—prostate cancer	3.86e-05	0.000132	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—FGFR2—prostate cancer	3.85e-05	0.000132	CbGpPWpGaD
Adenosine—ADA—Metabolism—PIK3CB—prostate cancer	3.84e-05	0.000132	CbGpPWpGaD
Adenosine—ADA—Metabolism—PTGS2—prostate cancer	3.81e-05	0.00013	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—BAD—prostate cancer	3.79e-05	0.00013	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—IL2—prostate cancer	3.71e-05	0.000127	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—FGF10—prostate cancer	3.71e-05	0.000127	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—TERT—prostate cancer	3.7e-05	0.000127	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—ADRB2—prostate cancer	3.67e-05	0.000126	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—APC—prostate cancer	3.67e-05	0.000126	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—PIK3CG—prostate cancer	3.67e-05	0.000126	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—IRS1—prostate cancer	3.62e-05	0.000124	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—EGF—prostate cancer	3.62e-05	0.000124	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—JAK2—prostate cancer	3.62e-05	0.000124	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—MAP2K1—prostate cancer	3.61e-05	0.000124	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—PIK3CD—prostate cancer	3.58e-05	0.000123	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—VAV3—prostate cancer	3.58e-05	0.000123	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—HIF1A—prostate cancer	3.54e-05	0.000121	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—TGFBR2—prostate cancer	3.53e-05	0.000121	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—GSK3B—prostate cancer	3.52e-05	0.000121	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—ITPR1—prostate cancer	3.47e-05	0.000119	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—INS—prostate cancer	3.47e-05	0.000119	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—LEP—prostate cancer	3.45e-05	0.000118	CbGpPWpGaD
Adenosine—ADK—Metabolism—PIK3CA—prostate cancer	3.44e-05	0.000118	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—PIK3CB—prostate cancer	3.44e-05	0.000118	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CAV1—prostate cancer	3.42e-05	0.000117	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CREBBP—prostate cancer	3.4e-05	0.000116	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—KDR—prostate cancer	3.38e-05	0.000116	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—IGF1—prostate cancer	3.36e-05	0.000115	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—EGFR—prostate cancer	3.34e-05	0.000114	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—IGF1R—prostate cancer	3.32e-05	0.000114	CbGpPWpGaD
Adenosine—ADA—Metabolism—PTEN—prostate cancer	3.32e-05	0.000114	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—CXCL8—prostate cancer	3.3e-05	0.000113	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—ESR1—prostate cancer	3.3e-05	0.000113	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—JAK2—prostate cancer	3.29e-05	0.000113	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—MAP2K1—prostate cancer	3.24e-05	0.000111	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—PIK3CD—prostate cancer	3.22e-05	0.00011	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—BAD—prostate cancer	3.22e-05	0.00011	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—PIK3CA—prostate cancer	3.19e-05	0.000109	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—SERPINE1—prostate cancer	3.19e-05	0.000109	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—LPL—prostate cancer	3.18e-05	0.000109	CbGpPWpGaD
Adenosine—ADA—Metabolism—EP300—prostate cancer	3.16e-05	0.000108	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—IL2—prostate cancer	3.16e-05	0.000108	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—KRAS—prostate cancer	3.16e-05	0.000108	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PDGFRB—prostate cancer	3.15e-05	0.000108	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—PIK3CB—prostate cancer	3.12e-05	0.000107	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—APC—prostate cancer	3.12e-05	0.000107	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PIK3CG—prostate cancer	3.12e-05	0.000107	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—FGF2—prostate cancer	3.09e-05	0.000106	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—IRS1—prostate cancer	3.08e-05	0.000106	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—EGF—prostate cancer	3.08e-05	0.000106	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—ITGB3—prostate cancer	3.07e-05	0.000105	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—NOS3—prostate cancer	3.04e-05	0.000104	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—CXCL8—prostate cancer	3e-05	0.000103	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—GSK3B—prostate cancer	2.99e-05	0.000102	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—ERBB3—prostate cancer	2.98e-05	0.000102	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—FGFR2—prostate cancer	2.98e-05	0.000102	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—JAK2—prostate cancer	2.96e-05	0.000101	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—INS—prostate cancer	2.95e-05	0.000101	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—PIK3CA—prostate cancer	2.9e-05	9.93e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CREBBP—prostate cancer	2.89e-05	9.9e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—MDM2—prostate cancer	2.89e-05	9.89e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—IL2—prostate cancer	2.87e-05	9.82e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—TERT—prostate cancer	2.86e-05	9.79e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—IGF1—prostate cancer	2.85e-05	9.78e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—ERBB2—prostate cancer	2.85e-05	9.75e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—EGFR—prostate cancer	2.84e-05	9.73e-05	CbGpPWpGaD
Adenosine—ADK—Metabolism—AKT1—prostate cancer	2.81e-05	9.64e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—PIK3CB—prostate cancer	2.81e-05	9.62e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—MAP2K1—prostate cancer	2.76e-05	9.45e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PIK3CD—prostate cancer	2.74e-05	9.39e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—HIF1A—prostate cancer	2.73e-05	9.36e-05	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—PIK3CA—prostate cancer	2.71e-05	9.3e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—SERPINE1—prostate cancer	2.71e-05	9.29e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CXCL8—prostate cancer	2.7e-05	9.25e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—KRAS—prostate cancer	2.68e-05	9.19e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—LEP—prostate cancer	2.67e-05	9.14e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CAV1—prostate cancer	2.64e-05	9.05e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CDKN1B—prostate cancer	2.64e-05	9.03e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—FGF2—prostate cancer	2.62e-05	8.99e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—KDR—prostate cancer	2.61e-05	8.95e-05	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—AKT1—prostate cancer	2.61e-05	8.93e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—NOS3—prostate cancer	2.59e-05	8.86e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CASP3—prostate cancer	2.58e-05	8.85e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—IL2—prostate cancer	2.58e-05	8.84e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—IL6—prostate cancer	2.57e-05	8.79e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—ESR1—prostate cancer	2.55e-05	8.72e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CCND1—prostate cancer	2.52e-05	8.62e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—JAK2—prostate cancer	2.52e-05	8.62e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CTNNB1—prostate cancer	2.49e-05	8.53e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—BAD—prostate cancer	2.49e-05	8.51e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—PIK3CA—prostate cancer	2.46e-05	8.44e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—MDM2—prostate cancer	2.46e-05	8.41e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—MMP9—prostate cancer	2.44e-05	8.36e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CDKN1A—prostate cancer	2.43e-05	8.33e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—PTEN—prostate cancer	2.43e-05	8.32e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—ERBB2—prostate cancer	2.42e-05	8.29e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—APC—prostate cancer	2.41e-05	8.25e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PIK3CG—prostate cancer	2.41e-05	8.25e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PIK3CB—prostate cancer	2.39e-05	8.18e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—EGF—prostate cancer	2.38e-05	8.15e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—IRS1—prostate cancer	2.38e-05	8.15e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—AKT1—prostate cancer	2.37e-05	8.11e-05	CbGpPWpGaD
Adenosine—ADA—Metabolism—PIK3CA—prostate cancer	2.34e-05	8.02e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—EP300—prostate cancer	2.32e-05	7.93e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—GSK3B—prostate cancer	2.31e-05	7.91e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CXCL8—prostate cancer	2.3e-05	7.86e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—INS—prostate cancer	2.28e-05	7.8e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—SRC—prostate cancer	2.25e-05	7.71e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CDKN1B—prostate cancer	2.24e-05	7.68e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CREBBP—prostate cancer	2.23e-05	7.64e-05	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—AKT1—prostate cancer	2.22e-05	7.6e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—IGF1—prostate cancer	2.2e-05	7.55e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CASP3—prostate cancer	2.2e-05	7.53e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—IL2—prostate cancer	2.19e-05	7.51e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—EGFR—prostate cancer	2.19e-05	7.51e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—VEGFA—prostate cancer	2.19e-05	7.51e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—IL6—prostate cancer	2.18e-05	7.48e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—STAT3—prostate cancer	2.17e-05	7.44e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CCND1—prostate cancer	2.14e-05	7.33e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—MAP2K1—prostate cancer	2.13e-05	7.3e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CTNNB1—prostate cancer	2.12e-05	7.25e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PIK3CD—prostate cancer	2.12e-05	7.25e-05	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—PIK3CA—prostate cancer	2.1e-05	7.18e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—SERPINE1—prostate cancer	2.09e-05	7.17e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—MMP9—prostate cancer	2.08e-05	7.11e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—KRAS—prostate cancer	2.07e-05	7.1e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CDKN1A—prostate cancer	2.07e-05	7.09e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PTEN—prostate cancer	2.06e-05	7.07e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—FGF2—prostate cancer	2.03e-05	6.94e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—MYC—prostate cancer	2.02e-05	6.91e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—AKT1—prostate cancer	2.01e-05	6.9e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—TGFB1—prostate cancer	2.01e-05	6.89e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—NOS3—prostate cancer	2e-05	6.84e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—EGFR—prostate cancer	1.97e-05	6.76e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—EP300—prostate cancer	1.97e-05	6.74e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—JAK2—prostate cancer	1.94e-05	6.65e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—SRC—prostate cancer	1.91e-05	6.56e-05	CbGpPWpGaD
Adenosine—ADA—Metabolism—AKT1—prostate cancer	1.91e-05	6.55e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—PIK3CA—prostate cancer	1.9e-05	6.52e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—MDM2—prostate cancer	1.9e-05	6.49e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—ERBB2—prostate cancer	1.87e-05	6.4e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—VEGFA—prostate cancer	1.86e-05	6.39e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—KRAS—prostate cancer	1.86e-05	6.39e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—STAT3—prostate cancer	1.85e-05	6.32e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PIK3CB—prostate cancer	1.84e-05	6.32e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CXCL8—prostate cancer	1.77e-05	6.07e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CDKN1B—prostate cancer	1.73e-05	5.93e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—MYC—prostate cancer	1.72e-05	5.88e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—PIK3CA—prostate cancer	1.71e-05	5.87e-05	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—AKT1—prostate cancer	1.71e-05	5.86e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—TGFB1—prostate cancer	1.71e-05	5.86e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CASP3—prostate cancer	1.7e-05	5.81e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—IL2—prostate cancer	1.69e-05	5.8e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—IL6—prostate cancer	1.69e-05	5.77e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—EGFR—prostate cancer	1.68e-05	5.75e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—TP53—prostate cancer	1.66e-05	5.68e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CCND1—prostate cancer	1.65e-05	5.66e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CTNNB1—prostate cancer	1.64e-05	5.6e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—MMP9—prostate cancer	1.6e-05	5.49e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CDKN1A—prostate cancer	1.6e-05	5.47e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PTEN—prostate cancer	1.59e-05	5.46e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—KRAS—prostate cancer	1.58e-05	5.43e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—AKT1—prostate cancer	1.55e-05	5.33e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—EP300—prostate cancer	1.52e-05	5.21e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—IL6—prostate cancer	1.52e-05	5.19e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—SRC—prostate cancer	1.48e-05	5.06e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PIK3CA—prostate cancer	1.46e-05	4.99e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—VEGFA—prostate cancer	1.44e-05	4.93e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—STAT3—prostate cancer	1.43e-05	4.88e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—TP53—prostate cancer	1.41e-05	4.83e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—AKT1—prostate cancer	1.4e-05	4.79e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—MYC—prostate cancer	1.32e-05	4.54e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—TGFB1—prostate cancer	1.32e-05	4.53e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—EGFR—prostate cancer	1.3e-05	4.44e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—IL6—prostate cancer	1.29e-05	4.42e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—KRAS—prostate cancer	1.22e-05	4.19e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—AKT1—prostate cancer	1.19e-05	4.07e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PIK3CA—prostate cancer	1.12e-05	3.85e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—TP53—prostate cancer	1.09e-05	3.73e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—IL6—prostate cancer	9.96e-06	3.41e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—AKT1—prostate cancer	9.18e-06	3.15e-05	CbGpPWpGaD
